Prolymphocytic leukemia: Difference between revisions
mNo edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} {{AE}} {{CLG}} {{MV}} | {{CMG}}; {{AE}} {{CLG}}, {{MV}} | ||
For more information regarding B-cell prolymphocytic leukemia, please click [[B-cell prolymphocytic leukemia|here]]. | |||
For more information regarding T-cell prolymphocytic leukemia, please click [[T-cell prolymphocytic leukemia|here]]. | |||
==Overview== | ==Overview== | ||
'''Prolymphocytic leukemia''' is a rare lymphoid leukemia, which account for only about 2% of all mature lymphoid leukemias. Prolymphocytic leukemias present | '''Prolymphocytic leukemia''' is a rare lymphoid leukemia, which account for only about 2% of all mature lymphoid leukemias. Prolymphocytic leukemias present similar to leukemia. Like lymphomas, they originate in the lymphocytes, but do not form solid tumors. Prolymphocytic leukemias are also considered lymphoproliferative disorders, which mean that lymphocytes are produced in large amounts. | ||
Prolymphocytic leukemia | Prolymphocytic leukemia may be classified according to the type of cell involved: [[B-cell prolymphocytic leukemia]] and [[T-cell prolymphocytic leukemia]]. Originally, it was thought to be a rare variation of chronic lymphocytic leukemia, but is now considered a distinct disease. It is usually classified as a kind of [[chronic lymphocytic leukemia]]. Although these 2 types of prolymphocytic leukemias share some of the same characteristics, the [[World Health Organization]] (WHO) classifies them as different types of lymphoid leukemias.<ref name=PL>{{cite web | title = World Health Organization| url =http://search.who.int/search?q=acute+prolymphocytic+leukemia&ie=utf8&site=who&client=_en_r&proxystylesheet=_en_r&output=xml_no_dtd&oe=utf8&getfields=doctype }}</ref> | ||
==Classification== | ==Classification== | ||
For more details about each specific type of prolymphocytic leukemia, click on the links in blue in the algorithm below.<br> | For more details about each specific type of prolymphocytic leukemia, click on the links in blue in the algorithm below.<br> | ||
{{Familytree/start}} | {{Familytree/start}} | ||
| Line 44: | Line 47: | ||
| | | | ||
*Elevated white blood cell count >100,000/microL | *Elevated white blood cell count >100,000/microL | ||
*Splenomegaly | *[[Splenomegaly]] | ||
*Generalized lymphadenopathy | *Generalized lymphadenopathy | ||
*Occasional skin involvement | *Occasional skin involvement | ||
| Line 51: | Line 54: | ||
| | | | ||
B symptoms | B symptoms | ||
:*Fever | :*[[Fever]] | ||
:*Swelling in the lymph nodes | :*Swelling in the lymph nodes | ||
:*Night sweats | :*[[Night sweats]] | ||
:*Persistent fatigue | :*Persistent [[fatigue]] | ||
| | | | ||
*Fever | *[[Fever]] | ||
*Persistent fatigue | *Persistent [[fatigue]] | ||
*Weight-loss | *[[Weight-loss]] | ||
|- | |- | ||
| '''Diagnosis''' | | '''Diagnosis''' | ||
| Line 67: | Line 70: | ||
| Peripheral blood smear | | Peripheral blood smear | ||
:*Medium-sized lymphoid cells | :*Medium-sized lymphoid cells | ||
:*Moderately condensed chromatin and a visible nucleolus | :*Moderately condensed chromatin and a visible nucleolus | ||
Biomarkers | Biomarkers | ||
:*CD52+ | :*CD52+ | ||
| Line 77: | Line 80: | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 14:25, 8 August 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Carlos A Lopez, M.D. [2], Maria Fernanda Villarreal, M.D. [3]
For more information regarding B-cell prolymphocytic leukemia, please click here. For more information regarding T-cell prolymphocytic leukemia, please click here.
Overview
Prolymphocytic leukemia is a rare lymphoid leukemia, which account for only about 2% of all mature lymphoid leukemias. Prolymphocytic leukemias present similar to leukemia. Like lymphomas, they originate in the lymphocytes, but do not form solid tumors. Prolymphocytic leukemias are also considered lymphoproliferative disorders, which mean that lymphocytes are produced in large amounts.
Prolymphocytic leukemia may be classified according to the type of cell involved: B-cell prolymphocytic leukemia and T-cell prolymphocytic leukemia. Originally, it was thought to be a rare variation of chronic lymphocytic leukemia, but is now considered a distinct disease. It is usually classified as a kind of chronic lymphocytic leukemia. Although these 2 types of prolymphocytic leukemias share some of the same characteristics, the World Health Organization (WHO) classifies them as different types of lymphoid leukemias.[1]
Classification
For more details about each specific type of prolymphocytic leukemia, click on the links in blue in the algorithm below.
| Prolymphocytic leukemia | |||||||||||||||||||||||||||||
| B-cell prolymphocytic leukemia | T-cell prolymphocytic leukemia | ||||||||||||||||||||||||||||
Differentiating B-Prolymphocytic Leukemia from T-Prolymphocytic Leukemia
In order to distinguish B-prolymphocytic leukemia from T-prolymphocytic leukemia, see the table below.
| Characteristics | B-PLL | T-PLL |
|---|---|---|
| Epidemiology |
|
|
| Age |
|
|
| Onset |
|
|
| Clinical Features |
B symptoms
|
|
| Diagnosis | Peripheral blood smear
Biomarkers
|
Peripheral blood smear
Biomarkers
|